They can identify questions to ask but cannot establish current cost, medical effectiveness, or service time
The current available information on Lixisenatide is that it was tested and it is safe for diabetes, however it was removed from the market as a result of a business decision. Why are we interested in GLP-1 diabetes drugs for Parkinsons disease
Similar content being viewed by others Introduction In recent years, GLP-1R and its agonists have garnered widespread attention in the medical community
doi: 10.1136/bmj.38856.692986.AE 2 ClausenTDMathiesenEEkbomPHellmuthEMandrup-PoulsenTDammP
If A1C is ,8% (64 mmol/mol) when starting mealtime bolus insulin, consideration should be given to decreasing the basal insulin dose
In this context, glucagon-like peptide-2 (GLP-2) and its sister molecule glucagon-like peptide-1 (GLP-1) are of particular interest, as being critically involved in hepatic lipid homeostasis 5,6